Pneumococcal

Study data suggest that both vaccines induce similar functional antibody responses against pneumococcal serotype 3.

Study is the first to compare SARS-CoV-2–associated sepsis and presumed bacterial sepsis on mortality and incidence.

Community pharmacies and organizations can collaborate to tailor strategies and interventions and address the challenges and specific needs of the community.

By educating their patients on the provisions of the Inflation Reduction Act, pharmacists can have an even greater impact by increasing vaccine uptake in historically underserved groups.

Senate Bill 219 will also allow pharmacists to independently administer influenza and COVID-19 tests waived by the clinical laboratory improvement amendments.

Best practices to train staff and team members to engage patients and to ease the new vaccine offerings into the workflow are also discussed.

Pharmacists can play a crucial role in educating parents and helping remind them about the childhood vaccine schedule, which can be quite complex.

Investigators from Griffith University stated that technology has helped the development of vaccines that are safe to use and induce strong immune responses against Strep A.

Antibiotic prescribing at hospital discharge is a component of pharmacist-led antimicrobial stewardship programs that is often overlooked.

Study shows maternal vaccination with Pfizer’s hexavalent capsular polysaccharide conjugate vaccine may protect infants against Group B Streptococcus.

If approved, the V116 vaccine would be the first pneumococcal conjugate vaccine specifically designed for adults.

High-risk patient populations for pneumococcal pneumonia are discussed by Christina Madison, PharmD, FCCP, AAHIVP.

Key opinion leaders discuss factors leading to the development of novel pneumococcal vaccines.

Despite injection site adverse effects, the overall benefit-risk balance for pneumococcal vaccination remains favorable.

COVID-19 is helping to shape current pharmacy practice, including increased vaccinations, access to care, and better interactions with patients.

Medical experts provide an overview of the signs and symptoms of pneumococcal infections.

As the COVID-19 Public Health Emergency and PREP Act Expansions end, the ability of technicians to immunize patients in the future remains unclear.

Immunocompromised status still appears to be one of the highest independent risk factors for pneumococcal pneumonia in middle-aged and older adults.

Pharmacists who immunize must ensure their knowledge about routine vaccinations for adults and children is up-to-date by reviewing the changes to the immunization schedule each year.

Myths, fears, distrust, and misinformation on immunizations can keep patients from benefiting from their protective effects.

Treatment for community-acquired pneumococcal disease is dependent on patient-specific factors, whereas prevention with vaccinations is dependent on age and comorbidities.

As the summer months approach, pharmacists can offer many services to ensure patients remain safe and healthy during their travels.

Study findings suggest surveillance and prevention programs are needed for this common and deadly complication of hospitalization.

The diagnosis should change from an influenza infection if the patient has gradually increasing chest pain after the original diagnosis.

From 2017 to 2021, Australia did not experience a large increase in infections of serotype 19A across all ethnic and age groups, unlike New Zealand.

PCV10 protection is likely to have reduced the incidence of pneumococcal disease among all ages by between 48% and 66%.

At least 150 minutes per week of moderate intensity aerobic activity, or 75 minutes of vigorous intensity aerobic activity found to improve outcomes in patients with flu or pneumonia.

Vaccination is especially important for older adults with any chronic health conditions because vaccines can prevent serious illness and resulting complications down the road.

The study shed light on the importance of the source of vaccine information and other factors that prevent lifesaving vaccination.

It is possible that the pandemic had a positive impact on influenza vaccination rates.